Akrimax Pharmaceuticals has introduced Suprenza (phentermine HCl) orally disintegrating tablets (ODT) for the management of exogenous obesity. The company has launched Suprenza ODT in 15mg and 30mg dosage strengths. Suprenza is ...
Tags: pharceumatical product, obesity drugs, clinical research